StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3038% below fair value
$3.70−0.63 (-14.55%)

Close on Nov 16, 2026Market cap $104.43MP/E –Yield –

Journey Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Journey Medical's ebitda for the twelve months ending Dec 31, 2020 was $7.86M. For fiscal 2021 it was -$34.88M, down 544.0% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2021Dec 31, 2021-$34.88M-544.0%
FY2020Dec 31, 2020$7.86M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$3.63M–

More Journey Medical figures

See a number that looks wrong?